6-Phosphogluconate dehydrogenase inhibition arrests growth and induces apoptosis in gastric cancer via AMPK activation and oxidative stress

Poor outcomes in advanced gastric cancer necessitate alternative therapeutic strategies. 6-Phosphogluconate dehydrogenase (6-PGDH), an enzyme that catalyzes the decarboxylation step in the oxidative pentose phosphate pathway, has been identified as a promising therapeutic target in many cancers. In...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Cheng, Du, Pan, Zhang, Zhenguo, Bao, Di
Formato: Online Artículo Texto
Lenguaje:English
Publicado: De Gruyter 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9961966/
https://www.ncbi.nlm.nih.gov/pubmed/36852400
http://dx.doi.org/10.1515/biol-2022-0514

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9961966/
https://www.ncbi.nlm.nih.gov/pubmed/36852400
http://dx.doi.org/10.1515/biol-2022-0514

Ejemplares similares